Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T22:42:52.112Z.
Calculation as of: 2026-10-06T22:42:52.112Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6423558485129ce458f63e69d797580679928a9eb272818a894d3cfd838ee462
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2013-12-16.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
3707.31x
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
PharmaCyte Biotech, Inc.
Market Cap
$4.53M
EV/Sales Ratio
N/A
TTM Avg
3707.31x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.40M
EV/Sales Ratio
12.91x
TTM Avg
5.50x
3Y Avg
15.32x
5Y Avg
34.36x
Market Cap
$4.72M
EV/Sales Ratio
0.50x
TTM Avg
5.83x
3Y Avg
31.22x
5Y Avg
31.22x
Market Cap
$4.86M
EV/Sales Ratio
N/A
TTM Avg
0.61x
3Y Avg
0.46x
5Y Avg
2.93x
Market Cap
$4.21M
EV/Sales Ratio
N/A
TTM Avg
15.56x
3Y Avg
15.94x
5Y Avg
15.35x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. (PMCB) | $4.53M | N/A | 3707.31x | N/A | N/A |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | N/A | N/A | N/A | N/A |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.40M | 12.91x | 5.50x | 15.32x | 34.36x |
| CalciMedica, Inc. (CALC)vs › | $4.69M | N/A | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $4.71M | N/A | 21.78x | 80.72x | 86.37x |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.72M | 0.50x | 5.83x | 31.22x | 31.22x |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | 0.17x | 0.77x | 0.77x | 0.77x |
| Xenetic Biosciences, Inc. (XBIO)vs › | $4.86M | N/A | 0.61x | 0.46x | 2.93x |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.21M | N/A | 15.56x | 15.94x | 15.35x |
| GRI Bio, Inc. (GRI)vs › | $4.15M | N/A | 66867.68x | 66867.68x | 66867.68x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2013-12-16 | 10499.14x |
| 2013-12-13 | 10687.85x |
| 2013-12-12 | 10799.09x |
| 2013-12-11 | 10842.26x |
| 2013-12-10 | 10842.26x |
| 2013-12-09 | 11177.08x |
| 2013-12-06 | 10928.04x |
| 2013-12-05 | 10842.26x |
| 2013-12-04 | 11065.29x |
| 2013-12-03 | 11133.91x |
| 2013-12-02 | 11400.10x |
| 2013-11-29 | 11442.72x |
| 2013-11-27 | 11013.82x |
| 2013-11-26 | 11356.94x |
| 2013-11-25 | 11271.16x |
| 2013-11-22 | 10799.09x |
| 2013-11-21 | 11099.60x |
| 2013-11-20 | 11013.82x |
| 2013-11-19 | 10928.04x |
| 2013-11-18 | 10833.96x |
| 2013-11-15 | 11313.77x |
| 2013-11-14 | 11313.77x |
| 2013-11-13 | 11656.89x |
| 2013-11-12 | 11605.97x |
| 2013-11-11 | 11356.94x |
| 2013-11-08 | 11957.39x |
| 2013-11-07 | 11605.97x |
| 2013-11-06 | 11227.99x |
| 2013-11-05 | 11957.39x |
| 2013-11-04 | 11185.38x |
| 2013-11-01 | 10584.92x |
| 2013-10-31 | 10799.09x |
| 2013-10-30 | 9761.44x |
| 2013-10-29 | 9761.44x |
| 2013-10-28 | 9906.98x |
| 2013-10-25 | 9993.32x |
| 2013-10-24 | 10207.49x |
| 2013-10-23 | 10138.87x |
| 2013-10-22 | 10113.41x |
| 2013-10-21 | 10284.97x |
| 2013-10-18 | 10499.14x |
| 2013-10-17 | 10542.31x |
| 2013-10-16 | 10413.36x |
| 2013-10-15 | 10499.14x |
| 2013-10-14 | 10584.92x |
| 2013-10-11 | 11271.16x |
| 2013-10-10 | 10842.26x |
| 2013-10-09 | 11185.38x |
| 2013-10-08 | 11185.38x |
| 2013-10-07 | 12300.51x |
| 2013-10-04 | 10928.04x |
| 2013-10-03 | 10241.80x |
| 2013-10-02 | 10327.58x |
| 2013-10-01 | 10327.58x |
| 2013-09-30 | 10584.92x |
| 2013-09-27 | 10628.09x |
| 2013-09-26 | 11227.99x |
| 2013-09-25 | 11305.47x |
| 2013-09-24 | 11614.27x |
| 2013-09-23 | 11957.39x |
| 2013-09-20 | 11700.05x |
| 2013-09-19 | 11571.66x |
| 2013-09-18 | 11442.72x |
| 2013-09-17 | 12000.56x |
| 2013-09-16 | 12514.68x |
| 2013-09-13 | 5392.04x |
| 2013-09-12 | 5447.71x |
| 2013-09-11 | 5522.10x |
| 2013-09-10 | 5670.89x |
| 2013-09-09 | 5112.95x |
| 2013-09-06 | 4145.85x |
| 2013-09-05 | 4257.44x |
| 2013-09-04 | 4722.27x |
| 2013-09-03 | 4830.26x |
| 2013-08-30 | 4852.58x |
| 2013-08-29 | 5075.75x |
| 2013-08-28 | 5168.86x |
| 2013-08-27 | 4897.21x |
| 2013-08-26 | 5328.69x |
| 2013-08-23 | 5410.52x |
| 2013-08-22 | 5317.65x |
| 2013-08-21 | 5484.91x |
| 2013-08-20 | 5578.02x |
| 2013-08-19 | 5447.71x |
| 2013-08-16 | 5410.52x |
| 2013-08-15 | 5001.36x |
| 2013-08-14 | 5856.87x |
| 2013-08-13 | 6154.44x |
| 2013-08-12 | 6336.82x |
| 2013-08-09 | 6325.54x |
| 2013-08-08 | 6132.12x |
| 2013-08-07 | 5522.10x |
| 2013-08-06 | 6042.85x |
| 2013-08-05 | 5578.02x |
| 2013-08-02 | 5596.50x |
| 2013-08-01 | 5670.89x |
| 2013-07-31 | 5484.91x |
| 2013-07-30 | 6147.00x |
| 2013-07-29 | 38.67x |
| 2013-07-26 | 38.64x |
| 2013-07-25 | 38.69x |
| 2013-07-24 | 38.01x |
| 2013-07-23 | 38.00x |
| 2013-07-22 | 38.10x |
| 2013-07-19 | 38.15x |
| 2013-07-18 | 38.26x |
| 2013-07-17 | 37.68x |
| 2013-07-16 | 37.87x |
| 2013-07-15 | 38.03x |
| 2013-07-12 | 37.28x |
| 2013-07-11 | 37.20x |
| 2013-07-10 | 37.19x |
| 2013-07-09 | 37.15x |
| 2013-07-08 | 37.02x |
| 2013-07-05 | 37.21x |
| 2013-07-03 | 37.08x |
| 2013-07-02 | 37.07x |
| 2013-07-01 | 37.19x |
| 2013-06-28 | 37.08x |
| 2013-06-27 | 37.12x |
| 2013-06-26 | 37.10x |
| 2013-06-25 | 37.17x |
| 2013-06-24 | 37.14x |
| 2013-06-21 | 37.13x |
| 2013-06-20 | 37.21x |
| 2013-06-19 | 37.26x |
| 2013-06-18 | 37.26x |
| 2013-06-17 | 37.40x |
| 2013-06-14 | 37.21x |
| 2013-06-13 | 37.21x |
| 2013-06-12 | 37.48x |
| 2013-06-11 | 37.58x |
| 2013-06-10 | 37.63x |
| 2013-06-07 | 37.05x |
| 2013-06-06 | 37.19x |
| 2013-06-05 | 37.21x |
| 2013-06-04 | 37.41x |
| 2013-06-03 | 37.82x |
| 2013-05-31 | 37.88x |
| 2013-05-30 | 37.97x |
| 2013-05-29 | 38.06x |
| 2013-05-28 | 38.03x |
| 2013-05-24 | 37.89x |
| 2013-05-23 | 37.96x |
| 2013-05-22 | 38.04x |
| 2013-05-21 | 38.01x |
| 2013-05-20 | 38.15x |
| 2013-05-17 | 37.36x |
| 2013-05-16 | 37.94x |
| 2013-05-15 | 38.79x |
| 2013-05-14 | 38.79x |
| 2013-05-13 | 39.46x |
| 2013-05-10 | 38.76x |
| 2013-05-09 | 38.76x |
| 2013-05-08 | 37.61x |
| 2013-05-07 | 37.45x |
| 2013-05-06 | 37.39x |
| 2013-05-03 | 37.43x |
| 2013-05-02 | 37.20x |
| 2013-05-01 | 36.88x |
| 2013-04-30 | 36.85x |
| 2013-04-29 | 36.93x |
| 2013-04-26 | 36.73x |
| 2013-04-25 | 36.65x |
| 2013-04-24 | 36.39x |
| 2013-04-23 | 36.56x |
| 2013-04-22 | 36.74x |
| 2013-04-19 | 36.51x |
| 2013-04-18 | 36.28x |
| 2013-04-17 | 36.24x |
| 2013-04-16 | 36.31x |
| 2013-04-15 | 36.23x |
| 2013-04-12 | 36.28x |
| 2013-04-11 | 36.28x |
| 2013-04-10 | 36.31x |
| 2013-04-09 | 36.16x |
| 2013-04-08 | 36.28x |
| 2013-04-05 | 36.32x |
| 2013-04-04 | 36.35x |
| 2013-04-03 | 36.37x |
| 2013-04-02 | 36.34x |
| 2013-04-01 | 36.25x |
| 2013-03-28 | 36.31x |
| 2013-03-27 | 36.56x |
| 2013-03-26 | 36.42x |
| 2013-03-25 | 10.73x |
| 2013-03-22 | 10.66x |
| 2013-03-21 | 10.62x |
| 2013-03-20 | 10.50x |
| 2013-03-19 | 10.56x |
| 2013-03-18 | 10.59x |
| 2013-03-15 | 10.51x |
| 2013-03-14 | 10.58x |
| 2013-03-13 | 10.44x |
| 2013-03-12 | 10.46x |
| 2013-03-11 | 10.46x |
| 2013-03-08 | 10.47x |
| 2013-03-07 | 10.50x |
| 2013-03-06 | 10.50x |
| 2013-03-05 | 10.51x |
| 2013-03-04 | 10.51x |
| 2013-03-01 | 10.52x |
| 2013-02-28 | 10.50x |
| 2013-02-27 | 10.49x |
| 2013-02-26 | 10.49x |
| 2013-02-25 | 10.50x |
| 2013-02-22 | 10.49x |
| 2013-02-21 | 10.49x |
| 2013-02-20 | 10.52x |
| 2013-02-19 | 10.52x |
| 2013-02-15 | 10.54x |
| 2013-02-14 | 10.57x |
| 2013-02-13 | 10.57x |
| 2013-02-12 | 10.59x |
| 2013-02-11 | 10.63x |
| 2013-02-08 | 10.36x |
| 2013-02-07 | 10.30x |
| 2013-02-06 | 10.29x |
| 2013-02-05 | 10.27x |
| 2013-02-04 | 10.28x |
| 2013-02-01 | 10.28x |
| 2013-01-31 | 10.27x |
| 2013-01-30 | 10.27x |
| 2013-01-29 | 10.26x |
| 2013-01-28 | 10.27x |
| 2013-01-25 | 10.26x |
| 2013-01-24 | 10.28x |
| 2013-01-23 | 10.28x |
| 2013-01-22 | 10.28x |
| 2013-01-18 | 10.30x |
| 2013-01-17 | 10.28x |
| 2013-01-16 | 10.31x |
| 2013-01-15 | 10.30x |
| 2013-01-14 | 10.33x |
| 2013-01-11 | 10.32x |
| 2013-01-10 | 10.27x |
| 2013-01-09 | 10.34x |
| 2013-01-08 | 10.38x |
| 2013-01-07 | 10.30x |
| 2013-01-04 | 10.30x |
| 2013-01-03 | 10.30x |
| 2013-01-02 | 10.38x |
